New success story for our customer PDC*line Pharma which enters into a licensing agreement with leading Korean pharmaceutical company LG Chem to develop PDC*lung cancer vaccine in Asia. PDC*line Pharma enters into licensing agreement with LG Chem to develop PDC*lung cancer vaccine in Asia
Any questions on business creation, dilutive and non-dilutive funding? We will be pleased to freely advise you at the upcoming MedTech Meetup 2019. Book your 10-minute face-to-face meeting now!
Proud to have supported a third of the biotech companies which are representing Belgium at BIO-Europe 2017 in Berlin, Europe’s largest life science partnering conference.
Our customer Univercells has been awarded a $12 Million grant by the Bill & Melinda Gates Foundation to develop a breakthrough vaccine manufacturing platform. Its aim is to drastically reduce the cost of vaccines whilst increasing their availability and affordability in developing countries. « Humanity’s greatest advances are not in its discoveries, but in how those discoveries[…]
The Deloitte Technology Fast 50 competition is an annual selection of the 50 fastest-growing technology companies within Belgium. The initiative is designed to encourage and promote entrepreneurial, fast-growing technology companies. On Wednesday 19th of November 2015, OncoDNA was named “Most Disruptive Innovator” in the Rising Star category. This award recognises companies that have developed a[…]
Our customer Univercells partners with Takeda Pharmaceutical Company Limited to produce affordable vaccines for All. Press release: http://www.univercells.com/newsroom/univercells-partners-takeda/
Through a reversible deal, MaSTherCell has been acquired by Orgenesis (a leader in the emerging fields of cellular therapy and re-generative medicine for the treatment of Type 1 Diabetes) in March 2015. MaSTherCell will be responsible for the development and the commercialization of Orgenesis’ product and will also maintain his CDMO core business activity in[…]